103 related articles for article (PubMed ID: 20592354)
1. Determination of glycodelin-A expression correlated to grading and staging in ovarian carcinoma tissue.
Tsviliana A; Mayr D; Kuhn C; Kunze S; Mylonas I; Jeschke U; Friese K
Anticancer Res; 2010 May; 30(5):1637-40. PubMed ID: 20592354
[TBL] [Abstract][Full Text] [Related]
2. Glycodelin in ovarian serous carcinoma: association with differentiation and survival.
Mandelin E; Lassus H; Seppälä M; Leminen A; Gustafsson JA; Cheng G; Bützow R; Koistinen R
Cancer Res; 2003 Oct; 63(19):6258-64. PubMed ID: 14559812
[TBL] [Abstract][Full Text] [Related]
3. Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
Scholz C; Heublein S; Lenhard M; Friese K; Mayr D; Jeschke U
BMC Res Notes; 2012 Oct; 5():551. PubMed ID: 23036050
[TBL] [Abstract][Full Text] [Related]
4. Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties.
Kämäräinen M; Leivo I; Koistinen R; Julkunen M; Karvonen U; Rutanen EM; Seppälä M
Am J Pathol; 1996 May; 148(5):1435-43. PubMed ID: 8623915
[TBL] [Abstract][Full Text] [Related]
5. Glycodelin expression in correlation to grading, nodal involvement and steroid receptor expression in human breast cancer patients.
Scholz C; Toth B; Barthell E; Mylonas I; Weissenbacher T; Friese K; Jeschke U
Anticancer Res; 2010 May; 30(5):1599-603. PubMed ID: 20592348
[TBL] [Abstract][Full Text] [Related]
6. Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients.
Richter C; Baetje M; Bischof A; Makovitzky J; Richter DU; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):2023-5. PubMed ID: 17649816
[TBL] [Abstract][Full Text] [Related]
7. Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors.
Jeschke U; Bischof A; Speer R; Briese V; Richter DU; Bergemann C; Mylonas I; Shabani N; Friese K; Karsten U
Anticancer Res; 2005; 25(3A):1581-9. PubMed ID: 16033064
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues.
Jeschke U; Kuhn C; Mylonas I; Schulze S; Friese K; Mayr D; Speer R; Briese V; Richter DU; Haase M; Karsten U
Histopathology; 2006 Mar; 48(4):394-406. PubMed ID: 16487361
[TBL] [Abstract][Full Text] [Related]
9. Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.
Jeschke U; Mylonas I; Kunert-Keil C; Dazert E; Shabani N; Werling M; Kuhn C; Janni W; Gerber B; Friese K
Oncol Rep; 2005 Mar; 13(3):413-9. PubMed ID: 15706409
[TBL] [Abstract][Full Text] [Related]
10. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
[TBL] [Abstract][Full Text] [Related]
11. Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer.
Bischof A; Briese V; Richter DU; Bergemann C; Friese K; Jeschke U
Anticancer Res; 2005; 25(3A):1639-44. PubMed ID: 16033074
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer.
Jeschke U; Mylonas I; Kunert-Keil C; Stahn R; Scholz C; Janni W; Kuhn C; Schröder E; Mayr D; Friese K
Histochem Cell Biol; 2009 Feb; 131(2):283-95. PubMed ID: 18853174
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity.
Scholz C; Toth B; Barthell E; Mylonas I; Weissenbacher T; Friese K; Jeschke U
Histol Histopathol; 2009 Apr; 24(4):467-71. PubMed ID: 19224449
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer-derived glycodelin impairs in vitro dendritic cell maturation.
Scholz C; Rampf E; Toth B; Brunnhuber R; Weissenbacher T; Friese K; Jeschke U
J Immunother; 2009 Jun; 32(5):492-7. PubMed ID: 19609241
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
16. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
17. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of glycodelin in human adenocarcinoma of the lung, squamous cell carcinoma of the lung and lung metastases of colonic adenocarcinoma.
Kunert-Keil C; Steinmüller F; Jeschke U; Gredes T; Gedrange T
Acta Histochem; 2011 Dec; 113(8):798-802. PubMed ID: 21168900
[TBL] [Abstract][Full Text] [Related]
19. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin as a prognostic marker in human serous carcinomas of the ovary: an immunohistochemical analysis.
Dian D; Brüning A; Mylonas I
Arch Gynecol Obstet; 2011 Aug; 284(2):437-43. PubMed ID: 20803206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
